KoreaTimes - Bio

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Entertainment & Arts

SCMP
Asia

The Korea Times

Business

Bio

Mon, February 6, 2023 | 22:41

HLB's US affiliate Verismo sets up Asia headquarters in Korea

HLB's US affiliate Verismo sets up Asia headquarters in Korea

Verismo Therapeutics, a new drug development company based in the U.S., established its Asia branch in Korea as part of its plan to facilitate clinical trials of its anti-cancer drug platform in the Asia region, the Korean biotech company HLB said Tuesday.

Baek Byung-yeul | 2022-02-15 17:16

Samsung Biologics to begin operations of 4th plant this year

Samsung Biologics to begin operations of 4th plant this year

Partial operations will begin in October of this year at Samsung Biologics' fourth plant currently being built in Songdo, west of Seoul. The move is part of efforts by the drug-manufacturing unit of Samsung Group to improve its capabilities in the contract manufacturing organization (CMO) business, its CEO said Thursday.

Baek Byung-yeul | 2022-01-13 16:24

Novavax COVID-19 vaccine gets approval

Novavax COVID-19 vaccine gets approval

A worker is seen at SK Bioscience's plant manufacturing the COVID-19 vaccine of U.S. biotech company Novavax in Andong, North Gyeongsang Province, in this photo. The Ministry of Food and Drug Safety on Wednesday authorized the use of Novavax's COVID-19 vaccine.

Kim Bo-eun | 2022-01-12 17:28

Nanocovax COVID-19 vaccine proven effective

Nanocovax COVID-19 vaccine proven effective

Nanocovax, a COVID-19 vaccine developed by Vietnamese biotech company Nanogen, has received confirmation of its safety and effectiveness, paving its way to the global biopharmaceutical market, Korean biotech company HLB said Monday.

Baek Byung-yeul | 2021-12-20 16:17

Samsung, SK responding to Omicron COVID-19 variant

Samsung, SK responding to Omicron COVID-19 variant

Samsung Biologics, SK Bioscience, Celltrion, Seegene and other Korean biotech firms are responding to the latest COVID-19 variant called Omicron at a time when the new mutation could become an even greater concern than the Delta variant, according to companies Wednesday.

Baek Byung-yeul | 2021-12-01 17:05

Seegene test kits capable of detecting Omicron variant

Seegene test kits capable of detecting Omicron variant

With the global community facing the spread of the Omicron variant of COVID-19, Korean biotechnology company Seegene said Wednesday that its test kit is fully able to detect the new mutation.

Baek Byung-yeul | 2021-12-01 11:18

SCM Lifesciences appoints founder Song as CEO again

SCM Lifesciences appoints founder Song as CEO again

SCM Lifescience appointed its founder and chief strategy officer (CSO) Song Sun-uk as its new CEO, Monday.

Anna J. Park | 2021-11-15 15:40

Celltrion's COVID-19 antibody treatment wins EU drug agency's recommendation

Celltrion's COVID-19 antibody treatment wins EU drug agency's recommendation

The European Union's drug agency has recommended the approval of a COVID-19 antibody treatment by Celltrion, paving the way for its sales in the region, the South Korean pharmaceutical giant said Friday.

2021-11-12 14:28

EU watchdog backs two COVID antibody treatments

CJ remains upbeat over approval for Batavia acquisition

CJ remains upbeat over approval for Batavia acquisition

A few days after CJ Group - a mid-tier conglomerate in Korea focused on food and beverages - said it plans to invest up to 10 trillion won until 2023, its entertainment affiliate said it is about to enter the highly-lucrative biopharma CDMO business.

Kim Yoo-chul | 2021-11-09 15:17

1 2 3 4 5 6 7

Top 10 Stories

1	2-year work experience prerequisite lifted for foreign shipyard welders

2	Families of Itaewon victims on collision course with Seoul City

3	President Yoon at odds with politician who helped him win election

4	9 fishermen, including 2 Vietnamese, missing in boat incident

5	LG publishes Korea's first group-level net zero report

6	VIDEOFilipina K-pop idol and K-drama actress react to stereotypes about the Philippines

7	Conflict reignites over relocation of POSCO Holdings to Pohang

8	FSC approves security token transactions in Korea

9	Hyundai Motor's technology helps team become WTCR double champion

10	Tasks lie ahead for Woori's next chairman nominee picked amid controversy

DARKROOM